Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$103.94 - $118.98 $608,672 - $696,746
5,856 Added 10.63%
60,955 $6.51 Million
Q1 2024

May 03, 2024

BUY
$115.19 - $132.77 $84,779 - $97,718
736 Added 1.35%
55,099 $6.64 Million
Q4 2023

Feb 08, 2024

BUY
$114.26 - $136.0 $87,523 - $104,176
766 Added 1.43%
54,363 $6.69 Million
Q3 2023

Nov 09, 2023

SELL
$122.0 - $145.31 $333,670 - $397,422
-2,735 Reduced 4.86%
53,597 $6.94 Million
Q2 2023

Aug 07, 2023

SELL
$122.5 - $147.16 $16,660 - $20,013
-136 Reduced 0.24%
56,332 $6.98 Million
Q1 2023

May 01, 2023

BUY
$133.98 - $160.47 $1.89 Million - $2.27 Million
14,137 Added 33.4%
56,468 $8.26 Million
Q4 2022

Feb 07, 2023

SELL
$129.72 - $159.85 $356,859 - $439,747
-2,751 Reduced 6.1%
42,331 $6.74 Million
Q3 2022

Oct 25, 2022

BUY
$126.59 - $161.18 $4,937 - $6,286
39 Added 0.09%
45,082 $6.01 Million
Q2 2022

Aug 08, 2022

BUY
$141.59 - $168.66 $207,287 - $246,918
1,464 Added 3.36%
45,043 $7.03 Million
Q1 2022

May 06, 2022

SELL
$129.64 - $160.7 $95,803 - $118,757
-739 Reduced 1.67%
43,579 $6.78 Million
Q4 2021

Feb 08, 2022

SELL
$119.87 - $145.67 $109,800 - $133,433
-916 Reduced 2.03%
44,318 $5.65 Million
Q3 2021

Oct 28, 2021

BUY
$128.64 - $184.79 $57,630 - $82,785
448 Added 1.0%
45,234 $5.89 Million
Q2 2021

Jul 27, 2021

BUY
$160.2 - $186.42 $433,501 - $504,452
2,706 Added 6.43%
44,786 $7.96 Million
Q1 2021

May 03, 2021

SELL
$150.19 - $173.5 $626,442 - $723,668
-4,171 Reduced 9.02%
42,080 $6.92 Million
Q4 2020

Feb 04, 2021

SELL
$140.71 - $165.05 $1.06 Million - $1.24 Million
-7,539 Reduced 14.02%
46,251 $7.63 Million
Q3 2020

Nov 06, 2020

BUY
$105.46 - $144.13 $5.67 Million - $7.75 Million
53,790 New
53,790 $7.67 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Texas Permanent School Fund Portfolio

Follow Texas Permanent School Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Texas Permanent School Fund, based on Form 13F filings with the SEC.

News

Stay updated on Texas Permanent School Fund with notifications on news.